$6.00Average Price Target
The highest estimate is 8.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
This list is based on the watchlists of people on Stock Events who follow MIST. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Show more...
FAQ
What is Milestone Pharmaceuticals stock price today?▼
The current price of MIST is $0.92 USD — it has increased by +0.22% in the past 24 hours. Watch Milestone Pharmaceuticals stock price performance more closely on the chart.
What is Milestone Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Milestone Pharmaceuticals stocks are traded under the ticker MIST.
Is Milestone Pharmaceuticals stock price growing?▼
MIST stock has fallen by -1.07% compared to the previous week, the month change is a -13% fall, over the last year Milestone Pharmaceuticals has showed a -54.34% decrease.
What is Milestone Pharmaceuticals market cap?▼
Today Milestone Pharmaceuticals has the market capitalization of 114.26M
When is the next Milestone Pharmaceuticals earnings date?▼
Milestone Pharmaceuticals is going to release the next earnings report on November 17, 2026.
What were Milestone Pharmaceuticals earnings last quarter?▼
MIST earnings for the last quarter are -0.21 USD per share, whereas the estimation was -0.2 USD resulting in a -7.69% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Milestone Pharmaceuticals revenue for the last year?▼
Milestone Pharmaceuticals revenue for the last year amounts to 1.55M USD.
What is Milestone Pharmaceuticals net income for the last year?▼
MIST net income for the last year is -63.06M USD.
How many employees does Milestone Pharmaceuticals have?▼
As of September 22, 2026, the company has 38 employees.
In which sector is Milestone Pharmaceuticals located?▼
Milestone Pharmaceuticals operates in the Health & Wellness sector.
When did Milestone Pharmaceuticals complete a stock split?▼
Milestone Pharmaceuticals has not had any recent stock splits.
Where is Milestone Pharmaceuticals headquartered?▼
Milestone Pharmaceuticals is headquartered in MONTREAL, Canada.